AA
GMED icon

Ancora Advisors’s Globus Medical GMED Stock Holding History

Ancora Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-281
Closed -$24.2K – 2154
2026
Q1 		$24.2K Buy
281
+100
+55% +$8.98K ﹤0.01% 1456
2025
Q4 		$15.8K Buy
+181
New +$13.7K ﹤0.01% 1648
2022
Q4 		– Sell
-20
Closed -$1K – 1858
2022
Q3 		$1K Hold
20
– – ﹤0.01% 1899
2022
Q2 		$1K Buy
+20
New +$1.31K ﹤0.01% 2073
2022
Q1 		– Sell
-61
Closed -$4K – 2456
2021
Q4 		$4K Sell
61
-200
-77% -$14.5K ﹤0.01% 2088
2021
Q3 		$20K Buy
261
+200
+328% +$16.1K ﹤0.01% 1479
2021
Q2 		$5K Buy
+61
New +$4.34K ﹤0.01% 1693
2021
Q1 		– Sell
-24
Closed -$2K – 1775
2020
Q4 		$2K Buy
+24
New +$1.38K ﹤0.01% 1378

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ancora Advisors's GMED Position: Q2 2026 in Review

Ancora Advisors sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 281 shares — an estimated $24.2K sold.

Ancora Advisors first reported a position in GMED in Q4 2020 and held it in 8 quarters. The position peaked at $24.2K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Ancora Advisors reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 281 Globus Medical shares in Q2 2026, an estimated $24.2K.
  • Ancora Advisors first reported a position in Globus Medical in Q4 2020 and held it in 8 quarters.
  • Ancora Advisors's Globus Medical position peaked at $24.2K in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.